AVITA Medical Inc. (RCEL)
NASDAQ: RCEL
· Real-Time Price · USD
5.54
-0.26 (-4.48%)
At close: Jun 13, 2025, 3:59 PM
5.50
-0.72%
After-hours: Jun 13, 2025, 05:21 PM EDT
AVITA Medical Revenue Breakdown
| Period Ending | Dec 31, 2024 |
|---|---|
| Lease Revenue Revenue | 358K |
| Lease Revenue Revenue Growth | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Jun 30, 2021 | Jun 30, 2020 |
|---|---|---|---|---|---|
| Australia Revenue | 312K | 222K | 33.26M | 28.95M | 13.8M |
| Australia Revenue Growth | +40.54% | -99.33% | +14.86% | +109.82% | n/a |
| European Union Revenue | 155K | 51K | n/a | n/a | n/a |
| European Union Revenue Growth | +203.92% | n/a | n/a | n/a | n/a |
| Japan Revenue | 1.43M | 3.37M | n/a | n/a | n/a |
| Japan Revenue Growth | -57.54% | n/a | n/a | n/a | n/a |
| United States Revenue | 62.16M | 46.36M | n/a | n/a | n/a |
| United States Revenue Growth | +34.08% | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 21.23M | 24.73M | 23.82M | 21.6M | 17.97M | 25.78M | 24.27M | 22.19M | 17.13M | 16.28M | 15.65M | 16.52M | 14.53M | 8.87M | 9.42M | 11.94M | 9.08M | 16.16M | 20.24M | 27.91M | 15.79M | 9.93M | 8.49M | 8.62M | 5.23M | 5.36M | 7.36M | 3.73M | 2.5M | 2.52M | 3.25M | 3.23M | 1.97M | 2.09M | 2.32M | 2.4M | 1.71M | 1.65M | 968.42K | 959.7K |
| Selling, General, and Administrative Revenue Growth | -14.15% | +3.83% | +10.27% | +20.24% | -30.31% | +6.23% | +9.37% | +29.53% | +5.21% | +4.07% | -5.28% | +13.67% | +63.89% | -5.88% | -21.11% | +31.52% | -43.80% | -20.18% | -27.47% | +76.74% | +58.94% | +17.01% | -1.53% | +64.97% | -2.54% | -27.16% | +97.27% | +49.08% | -0.50% | -22.47% | +0.60% | +63.84% | -5.73% | -10.11% | -3.07% | +40.27% | +3.59% | +70.35% | +0.91% | n/a |
| Research and Development Revenue | 4.85M | 5.43M | 4.89M | 5.19M | 6.76M | 6.84M | 7.62M | 6.86M | 4.96M | 5.94M | 4.43M | 4.84M | 5.78M | 3.39M | 3.97M | 5.41M | 4.36M | 4.71M | 3.68M | 4.06M | 3.3M | 2.42M | 1.55M | 1.42M | 2.49M | 2.56M | 275.78K | 2.9M | 1.97M | 1.98M | 1.44M | 1.43M | 908.23K | 963.39K | 711.07K | 733.59K | 563.96K | 544.42K | 1.09M | 1.08M |
| Research and Development Revenue Growth | -10.65% | +11.07% | -5.91% | -23.22% | -1.03% | -10.31% | +11.10% | +38.21% | -16.44% | +34.06% | -8.41% | -16.27% | +70.53% | -14.75% | -26.54% | +24.09% | -7.50% | +28.15% | -9.36% | +23.13% | +36.02% | +55.80% | +9.28% | -42.94% | -2.54% | +827.74% | -90.49% | +46.89% | -0.50% | +37.50% | +0.60% | +57.89% | -5.73% | +35.48% | -3.07% | +30.08% | +3.59% | -49.89% | +0.91% | n/a |
| Sales and Marketing Revenue | 14.11M | 15.14M | 15.97M | 12.64M | 10.22M | 16.38M | 15.02M | 9.78M | 9.32M | 8.46M | 7.72M | 6.45M | 6.82M | 3.52M | 4.15M | 4.8M | 4.67M | 4.56M | 6.17M | 7.11M | 5.66M | 4.39M | 3.96M | 3.67M | 2.44M | 2.5M | 528.79K | 2.35M | 1.1M | 1.1M | 1.29M | 1.29M | 662.14K | 702.35K | 726.07K | 749.06K | 550.85K | 531.76K | 741.68K | 735K |
| Sales and Marketing Revenue Growth | -6.83% | -5.16% | +26.33% | +23.73% | -37.64% | +9.09% | +53.52% | +5.01% | +10.11% | +9.55% | +19.70% | -5.38% | +93.81% | -15.15% | -13.70% | +2.89% | +2.38% | -26.12% | -13.23% | +25.67% | +28.99% | +10.76% | +8.07% | +50.19% | -2.54% | +373.68% | -77.51% | +114.01% | -0.50% | -14.66% | +0.60% | +94.22% | -5.73% | -3.27% | -3.07% | +35.98% | +3.59% | -28.30% | +0.91% | n/a |